William “Bill” Anderson, chief executive officer of Roche Pharmaceuticals, speaks during an interview on the sidelines of the 38th Annual JP Morgan Healthcare Conference in San Francisco, California, U.S. January 13, 2020. REUTERS/Stephen Lam
William “Bill” Anderson, chief executive officer of Roche Pharmaceuticals, speaks during an interview on the sidelines of the 38th Annual JP Morgan Healthcare Conference in San Francisco, California, U.S. January 13, 2020. REUTERS/Stephen Lam